Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Somaxon Pharmaceuticals Inc (NASDAQ:SOMX.DL)

CAPS Rating: No stars

A pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SOMX.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

SultanOfSwing (33.08)
Submitted August 25, 2010

Marketing deal with P&G for Silenor is a big, big deal.

zzlangerhans (99.75)
Submitted July 19, 2012

On my CAPS spreadsheet, the entry for Somaxon reads "Underperform if rising back above 0.5 on irrational optimism". Until today that is. Now it reads "Maintain underperform until bankruptcy". I was lucky to get another shot at Somaxon and I'd be… More

NASDAQ:SOMX.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about SOMX.DL.

No one has written a Pitch for SOMX.DL stock yet. Tell us why you think SOMX.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in SOMX.DL.

No players have picked SOMX.DL yet. Tell us why you think SOMX.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SOMX.DL.